Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 269

1.

Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.

Peters L, Grint D, Lundgren JD, Rockstroh JK, Soriano V, Reiss P, Grzeszczuk A, Sambatakou H, Mocroft A, Kirk O; EuroSIDA in EuroCoord.

AIDS. 2012 Sep 24;26(15):1917-26.

PMID:
22781222
2.

Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care.

Ganesan A, Krantz EM, Huppler Hullsiek K, Riddle MS, Weintrob AC, Lalani T, Okulicz JF, Landrum M, Agan B, Whitman TJ, Ross MJ, Crum-Cianflone NF; Infectious Disease Clinical Research Program HIV/STI Working Group.

HIV Med. 2013 Feb;14(2):65-76. doi: 10.1111/j.1468-1293.2012.01036.x. Epub 2012 Jul 19.

3.

Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.

Ryom L, Kirk O, Lundgren JD, Reiss P, Pedersen C, De Wit S, Buzunova S, Gasiorowski J, Gatell JM, Mocroft A; EuroSIDA in EuroCoord.

HIV Med. 2013 Sep;14(8):503-8. doi: 10.1111/hiv.12038. Epub 2013 Apr 16.

4.

Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.

Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, Gatell J, Phillips AN, Ledergerber B, Lundgren JD; EuroSIDA Study Group.

AIDS. 2010 Jul 17;24(11):1667-78. doi: 10.1097/QAD.0b013e328339fe53.

PMID:
20523203
5.

Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.

Soriano V, Mocroft A, Rockstroh J, Ledergerber B, Knysz B, Chaplinskas S, Peters L, Karlsson A, Katlama C, Toro C, Kupfer B, Vogel M, Lundgren J; EuroSIDA Study Group.

J Infect Dis. 2008 Nov 1;198(9):1337-44. doi: 10.1086/592171.

6.

Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?

Rockstroh JK, Peters L, Grint D, Soriano V, Reiss P, Monforte Ad, Beniowski M, Losso MH, Kirk O, Kupfer B, Mocroft A; EuroSIDA in EuroCoord.

J Hepatol. 2013 Aug;59(2):213-20. doi: 10.1016/j.jhep.2013.04.005. Epub 2013 Apr 11.

PMID:
23583272
7.

Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.

Lucas GM, Jing Y, Sulkowski M, Abraham AG, Estrella MM, Atta MG, Fine DM, Klein MB, Silverberg MJ, Gill MJ, Moore RD, Gebo KA, Sterling TR, Butt AA; NA-ACCORD of the IeDEA.

J Infect Dis. 2013 Oct 15;208(8):1240-9. doi: 10.1093/infdis/jit373. Epub 2013 Jul 31.

8.

Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.

Rossi C, Raboud J, Walmsley S, Cooper C, Antoniou T, Burchell AN, Hull M, Chia J, Hogg RS, Moodie EE, Klein MB; Canadian Observational Cohort (CANOC) Collaboration.

BMC Infect Dis. 2017 Apr 4;17(1):246. doi: 10.1186/s12879-017-2350-8.

9.

Relationship of hepatitis C viremia to HIV state and to infection by specific hepatitis C genotypes.

Pérez-Gracia T, Galán F, Fernández-Gutiérrez C, Girón JA, Rodríguez-Iglesias M.

Liver. 1999 Aug;19(4):288-93.

PMID:
10459626
10.

Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.

Tsui JI, Vittinghoff E, Shlipak MG, Bertenthal D, Inadomi J, Rodriguez RA, O'Hare AM.

Arch Intern Med. 2007 Jun 25;167(12):1271-6.

PMID:
17592100
11.

Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.

Rasch MG, Engsig FN, Feldt-Rasmussen B, Kirk O, Kronborg G, Pedersen C, Gerstoft J, Obel N.

Scand J Infect Dis. 2012 Sep;44(9):689-96. doi: 10.3109/00365548.2012.673730. Epub 2012 Jun 10.

PMID:
22680981
12.

Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: a cross-sectional study.

Lee JJ, Lin MY, Yang YH, Lu SN, Chen HC, Hwang SJ.

Am J Kidney Dis. 2010 Jul;56(1):23-31. doi: 10.1053/j.ajkd.2010.01.015. Epub 2010 Apr 18.

PMID:
20400217
13.

Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.

Kalayjian RC, Lau B, Mechekano RN, Crane HM, Rodriguez B, Salata RA, Krishnasami Z, Willig JH, Martin JN, Moore RD, Eron JJ, Kitahata MM.

AIDS. 2012 Sep 24;26(15):1907-15.

14.

Hepatitis C virus infection in an HIV-positive population in Normandy: antibodies, HCV RNA and genotype prevalence.

Mendel I, Clotteau L, Lambert S, Buffet-Janvresse C.

J Med Virol. 1995 Nov;47(3):231-6.

PMID:
8551274
15.

Low hepatitis C viremia levels in patients with anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis.

Giostra F, Manzin A, Lenzi M, Francesconi R, Solforosi L, Manotti P, Muratori L, Zauli D, Clementi M, Bianchi FB.

J Hepatol. 1996 Oct;25(4):433-8.

PMID:
8912141
16.

Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.

Canavese C, Hollò Z, Ciccone G, Ghisetti V, Barbui A, Fop F, Martina G, Forgnone F, Novo P, Thea A, Grill A, Marchiaro G.

J Nephrol. 2000 Sep-Oct;13(5):352-9.

PMID:
11063139
17.

Role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012.

Morlat P, Vivot A, Vandenhende MA, Dauchy FA, Asselineau J, Déti E, Gerard Y, Lazaro E, Duffau P, Neau D, Bonnet F, Chêne G; Groupe D’epidémiologie Clinique du Sida en Aquitaine (Gecsa).

PLoS One. 2013 Jun 12;8(6):e66223. doi: 10.1371/journal.pone.0066223. Print 2013.

18.

Hepatitis C virus (HCV) viremia in human immunodeficiency virus-seronegative and -seropositive patients with indeterminate HCV recombinant immunoblot assay.

Marcellin P, Martinot-Peignoux M, Elias A, Branger M, Courtois F, Level R, Erlinger S, Benhamou JP.

J Infect Dis. 1994 Aug;170(2):433-5.

PMID:
7518489
19.

Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.

Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD; HepaI.Co.N.A. Study Group; Italian Cohort Naive for Antiretrovirals Study Group.

Clin Infect Dis. 2005 Jun 15;40(12):e101-9. Epub 2005 May 5.

PMID:
15909251
20.

Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.

Bahirwani R, Barin B, Olthoff K, Stock P, Murphy B, Rajender Reddy K; Solid Organ Transplantation in HIV: Multi-Site Study Investigators.

Liver Transpl. 2013 Jun;19(6):619-26. doi: 10.1002/lt.23648.

Supplemental Content

Support Center